Mutated genes in regions of UPD
| Mutated gene . | Region of UPD . | Described . | References . |
|---|---|---|---|
| MPL | UPD1p | MPN, RARSt | 52 |
| NRAS | UPD1p | JMML, CMML | 49 |
| TET2 | UPD4q | sAML, MPN, MDS/MPD, | 53, 54 |
| JAK2 | UPD9p | PV, ET, IMF, RARSt | 55,–57 |
| CDKN2B | UPD9p | ALL | 4 |
| WT1 | UPD11p | AML | 6 |
| c-CBL | UPD11q | CMML, MDS/MPN, JMML | 49, 50, 58,–60 |
| FLT3ITD | UPD13 | AML | 6, 49 |
| TP53 | UPD17p | MDS, sAML | 61 |
| NF1 | UPD17q | JMML | 62 |
| CEBPa | UPD19q | AML | 6, 63 |
| RUNX1 | UPD21q | AML | 6 |
| Mutated gene . | Region of UPD . | Described . | References . |
|---|---|---|---|
| MPL | UPD1p | MPN, RARSt | 52 |
| NRAS | UPD1p | JMML, CMML | 49 |
| TET2 | UPD4q | sAML, MPN, MDS/MPD, | 53, 54 |
| JAK2 | UPD9p | PV, ET, IMF, RARSt | 55,–57 |
| CDKN2B | UPD9p | ALL | 4 |
| WT1 | UPD11p | AML | 6 |
| c-CBL | UPD11q | CMML, MDS/MPN, JMML | 49, 50, 58,–60 |
| FLT3ITD | UPD13 | AML | 6, 49 |
| TP53 | UPD17p | MDS, sAML | 61 |
| NF1 | UPD17q | JMML | 62 |
| CEBPa | UPD19q | AML | 6, 63 |
| RUNX1 | UPD21q | AML | 6 |
RARSt indicates refractory anemia with ring sideroblasts in transformation; JMML, juvenile myelomonocytic leukemia; sAML, secondary acute myeloid leukemia; PV, polycythemia vera; ET, essential thrombocytopenia; and IMF, idiopathic myelofibrosis.